Overview
Researchers rely on DATATRAK to keep tabs on their clinical data. The company develops online, hosted electronic data capture (EDC) software for the biotechnology, medical device, contract research, and pharmaceutical industries. Its software speeds up the process of gathering data during clinical trials by collecting and electronically transmitting trial data from remote research sites to sponsors. DATATRAK also offers project management, site
...
Read More assessment, training, and hosting services. Its products have been used to support hundreds of clinical trials involving patients in more than 50 countries.
Read Less
Read More assessment, training, and hosting services. Its products have been used to support hundreds of clinical trials involving patients in more than 50 countries.
Read Less
James R Ward
See more contacts
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
,
Software Publishers
,
Information
,
Data processing and preparation
,
Prepackaged software
All Other Telecommunications
,
Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers
,
Motion Picture and Video Industries
,
Newspaper, Periodical, Book, and Directory Publishers
,
Radio and Television Broadcasting Stations
,
Satellite Telecommunications
,
Software Publishers
,
Sound Recording Industries
View more , Web Search Portals, Libraries, Archives, and Other Information Services Wired and Wireless Telecommunications (except Satellite)
View fewer
View more , Web Search Portals, Libraries, Archives, and Other Information Services Wired and Wireless Telecommunications (except Satellite)
View fewer
?
?
?
Actual
?
Actual
$7.16 million
Actual
1.01%
$6
DEC
?
?
OTC:DTRK
Contacts
Get in Touch with 3 Principals* and 23 Contacts
-
James R WardPresident and Chief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2020 (12 month period) in USD
Annual Revenue 2014
$7.16 million
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2014 |
|---|---|
| Net Operating Cash | $1 |
| Net Investing Cash | -$1 |
| Net Financing Cash | -$0 |
| Net Change in Cash | $0 |
| Cash at Beginning of Period | $3 |
| Cash at End of Period | $4 |
| Capital Expenditure | -$0 |
| Assets (mil) | 2014 | ||
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $4 | ||
| Accounts Receivable | $1 | ||
| Inventories | $ | ||
| Other Current Assets | $1 | ||
| Asset Summary | |||
| Total Current Assets | $5 | ||
| Tangible Fixed Assets | $1 | ||
| Intangible Assets | $ | ||
| Total Assets | $6 | ||
| Liabilities (mil) | 2014 | ||
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $0 | ||
| Short-Term Debt | $0 | ||
| Other Current Liabilities | $4 | ||
| Liability Summary | |||
| Total Current Liabilities | $4 | ||
| Long-Term Debt | $0 | ||
| Other Long-Term Liabilities | $ | ||
| Total Liabilities | $8 | ||
| Stakeholder's Equity (mil) | 2014 | ||
|---|---|---|---|
| Equity | |||
| Common Stock | $ | ||
| Retained Earnings | -$66 | ||
| Equity Summary | |||
| Total Equity | -$2 | ||
| Shares Outstanding | 1,510,577 | ||